Soleno Therapeutics Stands With the Prader-Willi Syndrome Community

This Prader-Willi Syndrome Awareness Day, May 15, join Soleno Therapeutics in sharing messages of hope and kindness for the Prader-Willi syndrome communityREDWOOD CITY, Calif., May 15, 2024 (GLOBE N

GlobeNewswireMay 15 20:00

Soleno Therapeutics Is Maintained at Outperform by Oppenheimer

Soleno Therapeutics Is Maintained at Outperform by Oppenheimer

Dow JonesMay 13 20:46

Oppenheimer: The Soleno Therapeutics (SLNO.US) rating was maintained, and the target price was adjusted from better than the market to the better than the market rating, and the target price was adjusted from $65.00 to $59.00.

Oppenheimer: The Soleno Therapeutics (SLNO.US) rating was maintained, and the target price was adjusted from better than the market to the better than the market rating, and the target price was adjusted from $65.00 to $59.00.

Zhitong FinanceMay 13 20:40

Oppenheimer Maintains Outperform on Soleno Therapeutics, Lowers Price Target to $59

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and lowers the price target from $65 to $59.

BenzingaMay 13 20:36

Soleno Therapeutics (SLNO) Receives a Buy From Stifel Nicolaus

TipRanksMay 13 10:06

Soleno Therapeutics Initiated at Outperform by Baird

Soleno Therapeutics Initiated at Outperform by Baird

Dow JonesMay 10 17:29